Sign In to Follow Application
View All Documents & Correspondence

Anti Unc5 C Antibodies

Abstract: Antibodies that bind UNC5C and fragments thereof are described. Compositions comprising these antibodies, as well as methods, including therapeutic methods and therapeutic uses of the antibodies are also described.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
07 August 2025
Publication Number
35/2025
Publication Type
INA
Invention Field
BIOTECHNOLOGY
Status
Email
Parent Application

Applicants

ELI LILLY AND COMPANY
Lilly Corporate Center Indianapolis, IN 46285

Inventors

1. MCCARTHY, James
c/o Alchemab Therapeutics LtdEast Side Office 1.02Kings CrossLondon N1C 4AX
2. LEGG, Sandrine
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
3. LEWIS, Giles
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
4. MITCHELL, Laura Sophie
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
5. BARTON, Justin
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
6. JENKINS KNIGHT, Emma
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
7. MINTER, Ralph Raymond
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
8. FINCH, Donna
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
9. SIDOR, Michelle
c/o Alchemab Therapeutics LtdEast Side Office 1.02Kings CrossLondon N1C 4AX
10. GALSON, Jacob Daniel
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
11. OSBOURN, Jane Katharine
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
12. DIAS DO NASCIMENTO, Jorge Norman
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
13. KOLASINSKA-ZWIERZ, Paulina Maria
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX
14. PEDIADITAKIS, Iosif
25 Green StreetBrookline, Massachusetts 02446
15. HAWTHORNE, William James
c/o Alchemab Therapeutics Ltd East Side Office 1.02 Kings Cross London N1C 4AX

Specification

Documents

Application Documents

# Name Date
1 202517075240-STATEMENT OF UNDERTAKING (FORM 3) [07-08-2025(online)].pdf 2025-08-07
3 202517075240-Sequence Listing in PDF [07-08-2025(online)].pdf 2025-08-07
4 202517075240-REQUEST FOR EXAMINATION (FORM-18) [07-08-2025(online)].pdf 2025-08-07
5 202517075240-POWER OF AUTHORITY [07-08-2025(online)].pdf 2025-08-07
6 202517075240-FORM 18 [07-08-2025(online)].pdf 2025-08-07
7 202517075240-FORM 1 [07-08-2025(online)].pdf 2025-08-07
8 202517075240-DRAWINGS [07-08-2025(online)].pdf 2025-08-07
9 202517075240-DECLARATION OF INVENTORSHIP (FORM 5) [07-08-2025(online)].pdf 2025-08-07
10 202517075240-COMPLETE SPECIFICATION [07-08-2025(online)].pdf 2025-08-07
11 202517075240-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [07-08-2025(online)].pdf 2025-08-07